Treatment Options for Villous Adenoma
of the Ampulla of Vater by Hoyuela, C. et al.
HPB Surgery, 2000, Vol. 11, pp. 325-331
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 2000 OPA (Overseas Publishers Association) N.V.
Published by license under
the Harwood Academic Publishers imprint,
part of The Gordon and Breach Publishing Group.
Printed in Malaysia.
Clinical Series
Treatment Options for Villous Adenoma
of the Ampulla of Vater
C. HOYUELA*, E. CUGAT, E. VELOSO and C. MARCO
HPB Surgery, Department of Surgery, Hospital Mtua de Terrassa, Terrassa (Barcelona),
University of Barcelona, Spain
(Received 1 November 1997; In final form 21 December 1998)
Introduction: Duodenal villous adenoma arising
from the ampulla of Vater has a high risk of malig-
nant development. Excluding associated malignant
disease prior to resection of an adenoma of the am-
pulla is not always possible. Therefore, the surgical
procedure of choice to treat this rare tumour is still
controversial.
Objective: To evaluate retrospectively results of treat-
ment of villous adenoma arising from ampulla of
Vater with dysplasia or associated carcinoma limit-
ed to the ampulla.
Patients and Methods: From 1985 to 1996, eight
patients have been diagnosed with ampullary villous
adenoma suitable for resection. We have reviewed
treatment, morbidity, mortality, follow-up and final
outcome.
Results: Pancreatoduodenectomy (PD) was perfor-
med in 4 patients. Transduodenal ampullectomy and
endoscopic resection was performed in 2 pa-
tients each. There was no perioperative mortality.
None of the patients had biliary, pancreatic or in-
testinal leakage but two patients who underwent
PD had minorpostoperative complications.Themean
follow-up was 44 (range: 6-132) months. Villous
adenoma was associated with adenocarcinoma in
50% of the cases (4/8 patients). During the follow-
up both patients who underwent transduodenal
ampullectomy developed recurrent disease. All pa-
tients initially treated by PD are alive without
evidence of recurrent disease.
Conclusions: Treatment of villous adenoma of the
ampulla must be individualized within certain lim-
its. In our series, PD achieve good results and it ap-
pears to be the procedure of choice in order to treat
villous adenomas with proved presence of carcino-
ma, carcinoma in situ or severe dysplasia. Endoscopic
or local resection may be appropriate for small
benign tumours in high risk patients.
Keywords: Villous adenoma, ampulla vater, pancreatoduo-
denectomy
INTRODUCTION
Adenomas of the ampulla are rare neoplasms
with an incidence of 0.04-0.12% in post-mortem
series [1,2]. Thereby, the clinical aspects of ade-
noma of ampulla are not well known because
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of the lack of large series. These adenomas may
bleed and cause recurrent pancreatico-biliary
complications including jaundice, cholangitis
and pancreatitis [3,4], but the most important
issue of these tumours is their potential to de-
velope malignant changes [1, 2] and, probably,
this is the main problem in deciding appropriate
treatment for these tumours. Even with an accu-
rate preoperative study, differentiating between
benign adenoma and infiltrating carcinoma
prior to resection is not always possible with
reliability. Neither clinical presentation nor size
of the lesion correlate with the presence of asso-
ciated carcinoma. Endoscopy permits cholangio-
graphy, pancreatography and direct biopsies
as indicated [5] but, nevertheless, excluding a
carcinoma may be difficult in endoscopic biopsy
specimens [6-9] because of its low reported
sensitivity (42%) and specifity (79%) for detecting
malignancy [6]. Even intraoperative frozen-
section analysis of resected specimens may fail
to detect carcinoma in 14-33% of cases [4,10].
Therefore, it is not uncommon that the surgeon
cannot rely on results of the frozen-section study
during operation [8]. Endoscopic ultrasound
(EUS) can provide helpful information in asses-
sing depth of penetration [6,11,12] for local stag-
ing of ampullary tumours but is less accurate
determining the presence or absence of lymph
node metastases [11] and it cannot replace histo-
logic evaluation [6].
Due to the high risk of association of invasive
carcinoma and villous adenoma, the surgical
procedure of choice to treat this rare tumour is
still controversial [5,6,13,14]. Pancreatoduo-
denectomy (PD), transduodenal excision and
endoscopic resection have been reported as
therapeutic options, but each approach has dis-
advantages. The aim of this study has been to
evaluate retrospectively results of the treatment
of those patients who have been diagnosed of
villous adenoma of the papilla of Vater with
dysplasia or early associated carcinoma at our
Institution. We have reviewed treatment, mor-
bidity, mortality, follow-up and final outcome.
PATIENTS AND METHODS
FromMay 1985 to October 1996, 8 patients (4 men
and 4 women) have been diagnosed with
ampullary villous adenoma suitable for resec-
tion. The patients ranged from 39 to 72 years of
age with a mean of 59 years. None of them had
polyposis syndrome. Diagnosis was made on
the basis of endoscopy and biopsy in all patients.
Only those patients with histologically confirm-
ed areas of villous adenoma with or without
foci of adenocarcinoma have been included in
this study. No endoscopic ultrasonography (EUS)
was performed in any case. US and CT scan
showed no evidence of metastatic disease. The
clinical presentation, size, preoperative diagno-
sis, operation, final pathologic diagnosis and out-
come are summarized in Table I. Most common
manifestations of disease were jaundice (7/8
patients: 87.5%) and abdominal pain (3/8 pa-
tients: 37.5%). Preoperative biopsy showed focal
adenocarcinoma coexisting with areas of villous
tumour in 2/8 cases (25%) and severe cellular
atypia in 2 cases. In I patient preoperative biopsy
could not diagnose villous adenoma with severe
dysplasia correctly. Treatment decisionwas taken
on the basis of endoscopy (ERCP) and biopsy, size
and extent of the lesion alongCBD and pancreatic
duct and medical status of the patient (Tab. II).
RESULTS
Local resection was performed in 4 patients:
transduodenal ampullectomy in 2 patients and
endoscopic resection in 2 cases. The other 4
patients, including those with associated carci-
noma, underwent pancreatoduodenectomy (PD)
(2 Whipple’s procedure and 2 pylorus-preser-
ving PD). Intraoperative frozen-section studies
were performed in all patients but no additional
data to preoperative study were obtained in
any case. Moreover, intraoperative frozen study
were unable to find malignancy in one patient
with infiltrating carcinoma. This patient was0 0328 C. HOYUELA et al.
TABLE II Criteria for treatment decision in the series
Endosopic resection:
High-risk patients (ASA IV) (1 pat.)
Tumour diameter < cm. (1 pat.)
Local resection: (2 pat.)
No evidence of malignancy
Ampullary tumour without extension along
CBD or pancreatic duct
Tumour diameter < 3 cm.
Pancreatoduodenectomy:
Villous adenoma with associated carcinoma (2 pat.)
Tumour extension along CBD (1 pat.)
Undetermined diagnosis (1 pat.)
treated by ampullectomy and he refused a
second procedure when definitive postopera-
tive diagnosis was done (Case 2/Tab. I). Post-
operative pathological report confirmed initial
diagnosis in 4 cases (50%) only. One carcinoma
in situ and I infiltrating carcinoma were found at
final pathological examination in 2 patients with
preoperative diagnosis of benign villous adeno-
ma (Tab. I). Margins of the resected specimens
were free of tumour in all patients. No lymph
node metastasis were present in any case ini-
tially treated by PD.
There was no perioperative mortality. Mor-
bidity (2/8 patients: 25%): 1 case of delayed
gastric emptying after a pylorus-preserving PD
procedure, 1 urinary tract infection and I wound
infection. None of the patients had biliary, pan-
creatic or intestinal leakage. The mean follow-
up was 44 (range: 6-132) months. The two
patients who underwent transduodenal ampul-
lectomy were presented with recurrent disease
at 6 and 15 months after surgery (Tab. I). PD
were then performed in both cases and patho-
logical report of the specimen found infiltrat-
ing adenocarcinoma (1 patient died 18 months
after first procedure because of hepatic meta-
stases and the other one is without evidence of
disease progression 21 months after PD). All
patients initially treated by PD are alive without
evidence of recurrent disease.
DISCUSSION
Reported rates of neoplastic malignant changes
in duodenal villous adenoma are high: 20-47%
[1, 5, 7, 13]; previous studies have found residual
adenoma at the periphery of carcinoma of the
ampulla [2]. Such evidence supports the adeno-
ma-carcinoma sequence of the ampulla of Vater
and we agree with others who have recommend-
ed that all villous adenomas of the duodenum
be considered potentially malignant until pro-
ven otherwise [7,13,14].
The major focus of controversy in the manage-
ment of villous tumours of the ampulla relates to
the appropriate type of resection for adenomas
without invasive carcinoma. Is it necessary to
perform a radical procedure as PD? Can wide
local excision as transduodenal ampullectomy
provide adequate resection margins? Treatment
must achieve total excision of the mass in order to
avoid recurrent disease because the most im-
portant determinant of survival following sur-
gical treatment of an ampullary carcinoma is
complete resection [15]. The extent of the appro-
priate resection is determined by size, histologic
characteristics and location of the mass [8]. We
share the opinion that PD remains the procedure
of choice in treating adenomas containing in-
vasive cancer [5, 13, 14]. However, the best sur-
gical approach for benign lesions (villous and
tubulovillous adenomas, and specially those
with carcinoma in situ) confined to the ampulla
is less clear [5,6,12-14,16]. PD provides local
control of both extensive benign lesions and
cancers without distant metastases [7,14] but
several reports have advocated local ampullary
resection for patients with benign and premalig-
nant tumours and for selected patients with
malignant lesions [6,18,16] because local exci-
sion has had good results in terms of morbidity,
mortality and long-term survival. Therefore,
wide local excision as ampullectomy has been
proposed as the treatment of choice for these type
of lesions [3, 5, 6, 8].TREATMENT FOR VILLOUS ADENOMA OF THE AMPULLA 329
Nevertheless, can wide local resection of the
ampulla be considered an adequate procedure?
Ampullectomy is limited in tumours arising from
or extending along the distal biliary or pancreatic
ducts, since it may not be possible to obtain a
normal proximal ductal margin. One can gener-
ally resect the pancreatic and bile ducts for I cm
proximal to the ampulla [6,14]. Furthermore, it
can be difficult to reconstruct larger duodenal
mucosal defects if the size of the tumour is great-
er than 3cm [6]. In our series, one patient under-
went pylorus-preserving PD in order to treat a
villous adenoma without signs of malignancy
due to its proximal extension along common bile
duct (case 4/Tab. I). Moreover, recurrence of a
benign adenoma after adequate local removal is
nonetheless uncommon [5, 7,13]. The recurrence
rate of local excision in treating villous adenomas
was 28% in Cleveland Clinic’s series [13]. In the
same report, 62% of the patients treated by
duodenotomy and wide local excision had post-
operative complications, against 40% of those
patients treated by PD. In 64 patients collected
from different reports who underwent local
resection of any ampullary carcinoma, overall
mortality rate was 6% [15]. If local resection has
always been a tempting alternative for the treat-
ment of small ampullary tumours due to the
theoretical advantage of avoiding mortality and
morbidity of PD, this advantage is not very clear.
Transduodenalwide local excision of the ampulla
cannot be considered a minor procedure.
In the past, PD has been associated with a
high morbidity and mortality. However, large
series have documented more recently that com-
plication rates associated to PD are decreasing
because of improved perioperative care [13, 17,
18]. There were no deaths in a recent series of
142 consecutive patients who underwent PD
[18]. Morbidity and mortality following an ag-
gressive approach such PD have been low in
our series too. The pylorus-preserving modifica-
tion of the Whipple’s procedure [19] is actually
our procedure of choice because it is an appro-
priate oncological procedure and it reduces the
incidence oftroublesomepost-gastrectomysymp-
toms with better preserved gastro-intestinal
function [20].
The endoscopic approach has been proposed
as the least invasive approach to remove an am-
pullary adenoma [21,22]. However, local re-
currence after limited excision is a hazard [21]
because early carcinoma could be missed if the
lesion is not totally excised [3]. In a series of 25
patients treated by endoscopic snare excision
tumour recurred in 26% (mean follow-up 37
months). In our opinion, endoscopic approach
should be used only in patients who are at high
risk for medical reasons. It may be used also to
palliate some of the symptoms, as jaundice or
recurrent cholangitis [3, 9].
In conclusion, treatment of villous adenoma
of the ampulla must be individualized within
certain limits. The size, extent of the lesion, the
presence of a carcinoma and the medical status of
the patient must be evaluated. But, considering
the potentially high risk of malignancy of villous
adenoma of the ampulla of Vater and
the uncertainty of obtaining accurate pathologic
diagnosis before surgery, PD appears to be the
procedure of choice in order to treat villous
adenomas with proved presence of carcinoma,
carcinoma in situ or severe dysplasia. PD pro-
vides local control with acceptable morbidity
of both extensive benign lesions and cancers
without distant metastases and it achieves good
results in our series. Endoscopic or local resection
may be appropriate for small benign tumours in
high risk patients. If an infiltranting carcinoma is
found or if margins are involved, the procedure
should be converted to a PD.
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COMMENTARY
This interesting case series of eight patients
illustrates several facets of the management of
villous adenomas of the duodenum. The treat-
ment of this disease is influenced by emerging
facts regarding its natural history as well as
advances in endoscopic surgery and open sur-
gery. Of key importance is the fact that about
40% of villous adenomas actually contain inva-
sive ampullary cancer (3 of 8, or 38% in this
series). Recurrence after surgical ampullectomy
has been frequently reported and happened in
both patients in this series. Surgical ampullect-
omy is also limited by the size of the tumor.
Endoscopic methods are minimally invasive and
can completely excise or destroy small benign
lesions. They also provide close follow-up after
excision and close follow-up with biopsy is an
integral part of local excision. Pancreaticoduode-
nectomy has emerged now as a safe procedure
with a mortality rate of equal to, or less than, 1%
in specialized HPB centers. Importantly, the
quality of life after pancreaticoduodenectomy is
very high and equivalent to that of cholecys-
tectomy.
Given these facts, pancreaticoduodenectomy
must be considered the treatment of choice for a
villous adenomas that contain invasive cancer,
cancer in situ, or in which the pathology is un-
certain. Pancreaticoduodenectomy is also indi-
cated for lesions larger than 3 cm. in diameter.
For smaller lesions, particularly in high risk pa-
tients, local excision becomes competitive withTREATMENT FOR VILLOUS ADENOMA OF THE AMPULLA 331
pancreaticoduodenectomy. It should be noted
that the oldest patient in this series is 72 years.
Therefore all patients were well within the age
range in which pancreaticoduodenectomy is
commonly performed very safely.
In small lesions patient input is particularly
important.
Pancreaticoduodenectomy offers the greatest
chance of long-term cure, but while safe, is a
very invasive procedure. When choosing be-
tween the type of local excision, endoscopic
excision and close follow-up is probably as
effective in skilled hands as ampullectomy, and
is much less invasive. As a result, ampullectomy
is being used less and less.
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